UNSPSC 51285102: Bismuth subsalicylate/metronidazole/tetracycline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA303. This VA Drug Class (GA303) classifies this compound as belonging to the group H. PYLORI AGENTS.

UNSPSC 51285102 Bismuth subsalicylate/metronidazole/tetracycline is a Commodity code that in recent state and local procurement shows little activity directly aligned with the code's nominal pharmaceutical composition. The recent opportunities tagged to this code predominantly solicit naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals through cooperative purchasing — none of which centers on the specific bismuth subsalicylate/metronidazole/tetracycline combination the code names. The issuing bodies across recent solicitations span county health departments, state health and human services agencies, municipal fire departments, and multistate cooperative purchasing alliances, indicating fragmented demand across public health, emergency response, and pharmacy benefit administration functions. Where actual pharmaceutical procurement occurs under codes in this family, state and local governments are buying through cooperative vehicles with multiple-award structures, requiring compliance with FDA manufacturing standards and Drug Supply Chain Security Act certification, and often designating sheltered market opportunities for small business enterprises.

Recent activity concentrates in Florida, Texas, and Minnesota. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP due March 26, 2026, for generic multi-source pharmaceuticals and OTC products to be distributed through authorized wholesalers with an effective date of July 1, 2026. Seminole County, Florida issued IFB 60459723LAS in June 2026 for naloxone and drug deactivation systems with a response deadline of July 26, 2023 (record appears to contain a date discrepancy). The City of Tampa issued ITB 26P00145 in March 2026 for medical and first aid supplies for the Tampa Fire Department with a deadline of March 13, 2026 and an estimated contract value of $700,000, designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 as an exploratory market intelligence gathering for direct-to-manufacturer prescription programs. The code shows no clear concentration of demand around its named pharmaceutical combination.